Lifecore Common Stock vs Short Term Investments Analysis

LFCR Stock

5.87 0.10 1.73%

Lifecore Biomedical financial indicator trend analysis is infinitely more than just investigating Lifecore Biomedical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lifecore Biomedical is a good investment. Please check the relationship between Lifecore Biomedical Common Stock and its Short Term Investments accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lifecore Biomedical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Lifecore Stock, please use our How to Invest in Lifecore Biomedical guide.

Common Stock vs Short Term Investments

Common Stock vs Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Lifecore Biomedical Common Stock account and Short Term Investments. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Lifecore Biomedical's Common Stock and Short Term Investments is 0.83. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Short Term Investments in the same time period over historical financial statements of Lifecore Biomedical, assuming nothing else is changed. The correlation between historical values of Lifecore Biomedical's Common Stock and Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of Lifecore Biomedical are associated (or correlated) with its Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Investments has no effect on the direction of Common Stock i.e., Lifecore Biomedical's Common Stock and Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.83

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Common Stock

Short Term Investments

Short Term Investments is an item under the current assets section of Lifecore Biomedical balance sheet. It contains any investments Lifecore Biomedical undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Lifecore Biomedical can easily liquidate in the marketplace.

Most indicators from Lifecore Biomedical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lifecore Biomedical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lifecore Biomedical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Lifecore Stock, please use our How to Invest in Lifecore Biomedical guide.At this time, Lifecore Biomedical's Selling General Administrative is relatively stable compared to the past year. As of 05/17/2024, Tax Provision is likely to grow to about 363.5 K, while Enterprise Value Over EBITDA is likely to drop 7.98.

	2021	2023	2024 (projected)
Total Revenue	185.8M	213.7M	323.1M
Interest Expense	17.4M	19.9M	20.8M

Total Revenue Interest Expense

Lifecore Biomedical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Net Receivables	Intangible Assets	Common Stock	Current Deferred Revenue	Short Term Investments
Total Assets		0.58	0.68	0.88	0.81	0.83	0.59	0.55	0.91	-0.51	0.98	-0.71	-0.51	0.71	0.7	0.45	-0.29	0.7	0.8	0.8	0.56	0.97	0.26	-0.68	-0.46	-0.67
Short Long Term Debt Total	0.58		0.57	0.76	0.08	0.87	1.0	-0.32	0.39	-0.8	0.45	-0.54	-0.8	0.55	0.94	0.95	0.09	0.7	0.95	0.86	0.87	0.68	-0.28	-0.41	-0.33	-0.15
Other Current Liab	0.68	0.57		0.71	0.41	0.68	0.56	0.13	0.44	-0.38	0.63	-0.33	-0.39	0.71	0.59	0.51	-0.39	0.7	0.67	0.66	0.53	0.66	0.03	-0.65	-0.56	-0.52
Total Current Liabilities	0.88	0.76	0.71		0.53	0.85	0.76	0.25	0.74	-0.61	0.8	-0.65	-0.61	0.62	0.7	0.62	-0.02	0.72	0.88	0.89	0.85	0.89	0.1	-0.52	-0.44	-0.45
Total Stockholder Equity	0.81	0.08	0.41	0.53		0.5	0.09	0.88	0.88	-0.16	0.9	-0.46	-0.16	0.49	0.25	-0.02	-0.41	0.31	0.38	0.33	0.15	0.7	0.44	-0.6	-0.29	-0.7
Property Plant And Equipment Net	0.83	0.87	0.68	0.85	0.5		0.88	0.1	0.64	-0.86	0.75	-0.6	-0.86	0.68	0.86	0.8	-0.07	0.76	0.94	0.84	0.81	0.86	-0.23	-0.58	-0.34	-0.39
Net Debt	0.59	1.0	0.56	0.76	0.09	0.88		-0.31	0.39	-0.83	0.45	-0.54	-0.83	0.55	0.93	0.95	0.1	0.71	0.94	0.86	0.87	0.68	-0.31	-0.4	-0.31	-0.15
Retained Earnings	0.55	-0.32	0.13	0.25	0.88	0.1	-0.31		0.71	0.2	0.69	-0.38	0.21	0.1	-0.14	-0.47	-0.25	-0.06	-0.01	-0.02	-0.19	0.38	0.56	-0.25	-0.1	-0.54
Accounts Payable	0.91	0.39	0.44	0.74	0.88	0.64	0.39	0.71		-0.27	0.94	-0.71	-0.27	0.49	0.53	0.22	-0.24	0.4	0.65	0.58	0.4	0.83	0.5	-0.55	-0.36	-0.63
Cash	-0.51	-0.8	-0.38	-0.61	-0.16	-0.86	-0.83	0.2	-0.27		-0.41	0.39	1.0	-0.45	-0.72	-0.81	-0.19	-0.67	-0.74	-0.69	-0.74	-0.62	0.6	0.28	0.03	0.08
Non Current Assets Total	0.98	0.45	0.63	0.8	0.9	0.75	0.45	0.69	0.94	-0.41		-0.7	-0.41	0.63	0.58	0.29	-0.31	0.58	0.7	0.67	0.45	0.91	0.33	-0.65	-0.43	-0.7
Non Currrent Assets Other	-0.71	-0.54	-0.33	-0.65	-0.46	-0.6	-0.54	-0.38	-0.71	0.39	-0.7		0.4	-0.15	-0.64	-0.28	-0.24	-0.29	-0.66	-0.57	-0.43	-0.64	-0.1	0.1	0.23	0.23
Cash And Short Term Investments	-0.51	-0.8	-0.39	-0.61	-0.16	-0.86	-0.83	0.21	-0.27	1.0	-0.41	0.4		-0.45	-0.72	-0.8	-0.2	-0.66	-0.74	-0.69	-0.74	-0.61	0.61	0.27	0.03	0.07
Common Stock Shares Outstanding	0.71	0.55	0.71	0.62	0.49	0.68	0.55	0.1	0.49	-0.45	0.63	-0.15	-0.45		0.65	0.62	-0.7	0.89	0.67	0.75	0.46	0.8	0.12	-0.94	-0.58	-0.68
Non Current Liabilities Total	0.7	0.94	0.59	0.7	0.25	0.86	0.93	-0.14	0.53	-0.72	0.58	-0.64	-0.72	0.65		0.87	-0.13	0.73	0.95	0.86	0.69	0.77	-0.12	-0.55	-0.41	-0.33
Inventory	0.45	0.95	0.51	0.62	-0.02	0.8	0.95	-0.47	0.22	-0.81	0.29	-0.28	-0.8	0.62	0.87		-0.03	0.73	0.86	0.8	0.82	0.59	-0.35	-0.47	-0.3	-0.13
Other Current Assets	-0.29	0.09	-0.39	-0.02	-0.41	-0.07	0.1	-0.25	-0.24	-0.19	-0.31	-0.24	-0.2	-0.7	-0.13	-0.03		-0.39	-0.07	-0.13	0.23	-0.3	-0.44	0.81	0.52	0.72
Other Stockholder Equity	0.7	0.7	0.7	0.72	0.31	0.76	0.71	-0.06	0.4	-0.67	0.58	-0.29	-0.66	0.89	0.73	0.73	-0.39		0.75	0.91	0.6	0.83	-0.12	-0.7	-0.48	-0.46
Total Liab	0.8	0.95	0.67	0.88	0.38	0.94	0.94	-0.01	0.65	-0.74	0.7	-0.66	-0.74	0.67	0.95	0.86	-0.07	0.75		0.91	0.84	0.85	-0.06	-0.58	-0.44	-0.38
Total Current Assets	0.8	0.86	0.66	0.89	0.33	0.84	0.86	-0.02	0.58	-0.69	0.67	-0.57	-0.69	0.75	0.86	0.8	-0.13	0.91	0.91		0.78	0.9	-0.02	-0.57	-0.44	-0.4
Short Term Debt	0.56	0.87	0.53	0.85	0.15	0.81	0.87	-0.19	0.4	-0.74	0.45	-0.43	-0.74	0.46	0.69	0.82	0.23	0.6	0.84	0.78		0.64	-0.23	-0.33	-0.31	-0.12
Net Receivables	0.97	0.68	0.66	0.89	0.7	0.86	0.68	0.38	0.83	-0.62	0.91	-0.64	-0.61	0.8	0.77	0.59	-0.3	0.83	0.85	0.9	0.64		0.16	-0.72	-0.46	-0.64
Intangible Assets	0.26	-0.28	0.03	0.1	0.44	-0.23	-0.31	0.56	0.5	0.6	0.33	-0.1	0.61	0.12	-0.12	-0.35	-0.44	-0.12	-0.06	-0.02	-0.23	0.16		-0.28	-0.33	-0.44
Common Stock	-0.68	-0.41	-0.65	-0.52	-0.6	-0.58	-0.4	-0.25	-0.55	0.28	-0.65	0.1	0.27	-0.94	-0.55	-0.47	0.81	-0.7	-0.58	-0.57	-0.33	-0.72	-0.28		0.6	0.83
Current Deferred Revenue	-0.46	-0.33	-0.56	-0.44	-0.29	-0.34	-0.31	-0.1	-0.36	0.03	-0.43	0.23	0.03	-0.58	-0.41	-0.3	0.52	-0.48	-0.44	-0.44	-0.31	-0.46	-0.33	0.6		0.51
Short Term Investments	-0.67	-0.15	-0.52	-0.45	-0.7	-0.39	-0.15	-0.54	-0.63	0.08	-0.7	0.23	0.07	-0.68	-0.33	-0.13	0.72	-0.46	-0.38	-0.4	-0.12	-0.64	-0.44	0.83	0.51

Click cells to compare fundamentals

Lifecore Biomedical Account Relationship Matchups

Lifecore Biomedical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	541.3M	502.9M	295.2M	295.4M	339.8M	246.8M
Short Long Term Debt Total	221.1M	221.4M	153.2M	153.1M	176.1M	184.9M
Other Current Liab	19.0M	20.3M	16.9M	17.1M	19.6M	12.6M
Total Current Liabilities	164.4M	101.9M	79.2M	79.4M	91.3M	55.4M
Total Stockholder Equity	231.0M	202.8M	107.9M	108.1M	124.4M	139.4M
Property Plant And Equipment Net	200.0M	217.7M	200.4M	139.0M	159.9M	167.9M
Net Debt	220.8M	220.1M	151.5M	151.4M	174.2M	182.9M
Retained Earnings	71.2M	38.6M	(58.9M)	(58.7M)	(67.5M)	(64.1M)
Accounts Payable	54.0M	51.6M	47.6M	15.8M	18.2M	23.5M
Cash	1.1M	360K	1.3M	1.6M	1.5M	1.4M
Non Current Assets Total	386.1M	384.2M	354.6M	171.4M	197.2M	160.7M
Non Currrent Assets Other	(9.7M)	(25.3M)	(26.7M)	3.0M	2.7M	2.8M
Cash And Short Term Investments	1.1M	360K	1.3M	1.6M	1.5M	1.4M
Common Stock Shares Outstanding	29.2M	29.3M	29.5M	29.5M	33.9M	25.9M
Liabilities And Stockholders Equity	541.3M	502.9M	295.2M	295.4M	339.8M	246.8M
Non Current Liabilities Total	145.9M	198.3M	108.0M	107.9M	124.1M	130.3M
Inventory	66.3M	69.7M	66.8M	67.0M	77.0M	80.9M
Other Current Assets	8.3M	14.2M	7.4M	7.1M	6.3M	9.0M
Other Stockholder Equity	160.3M	162.6M	165.5M	167.4M	192.5M	118.6M
Total Liab	310.3M	300.1M	187.2M	187.3M	215.4M	226.2M
Total Current Assets	157.1M	148.3M	123.7M	124.0M	142.6M	86.1M
Short Term Debt	61.8M	93.4M	32.9M	45.6M	52.5M	55.1M
Net Receivables	76.2M	70.0M	48.2M	48.3M	55.6M	35.4M
Intangible Assets	45.2M	38.1M	36.1M	15.6M	17.9M	17.0M
Current Deferred Revenue	499K	352K	1.1M	919K	827.1K	1.3M
Good Will	54.5M	76.7M	69.4M	13.9M	16.0M	15.2M
Accumulated Other Comprehensive Income	64K	(2.8M)	(1.4M)	(586K)	(527.4K)	(553.8K)
Other Liab	14.6M	11.3M	422K	3.5M	3.1M	3.0M
Net Tangible Assets	123.6M	143.2M	78.5M	(19.9M)	(17.9M)	(17.0M)
Other Assets	2.2M	157.7M	3.0M	3.2M	3.7M	3.5M
Long Term Debt	101.4M	164.9M	97.6M	101.3M	116.5M	121.5M
Capital Lease Obligations	30.8M	27.5M	15.0M	11.0M	9.9M	14.1M
Net Invested Capital	421.4M	396.7M	246.1M	99.9M	89.9M	85.4M
Short Long Term Debt	89.0M	29M	40.6M	488K	439.2K	417.2K
Non Current Liabilities Other	4.6M	3.6M	190K	3.1M	2.8M	2.1M
Net Working Capital	(7.3M)	46.4M	44.5M	60.5M	69.6M	73.0M
Property Plant Equipment	217.7M	137.4M	139.0M	134.6M	121.1M	132.6M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Lifecore Biomedical is a strong investment it is important to analyze Lifecore Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Lifecore Biomedical's future performance. For an informed investment choice regarding Lifecore Stock, refer to the following important reports:

How To Invest In Lifecore

Details

Is Lifecore Stock a good investment?

Details

What is Lifecore Biomedical's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lifecore Biomedical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Lifecore Stock, please use our How to Invest in Lifecore Biomedical guide.

Note that the Lifecore Biomedical information on this page should be used as a complementary analysis to other Lifecore Biomedical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Lifecore Stock analysis

When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.

	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Global Correlations Find global opportunities by holding instruments from different markets
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope

Is Lifecore Biomedical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lifecore Biomedical. If investors know Lifecore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lifecore Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.14)

Revenue Per Share

3.447

Quarterly Revenue Growth

0.208

Return On Assets

(0.05)

Return On Equity

(1.05)

The market value of Lifecore Biomedical is measured differently than its book value, which is the value of Lifecore that is recorded on the company's balance sheet. Investors also form their own opinion of Lifecore Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Lifecore Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lifecore Biomedical's market value can be influenced by many factors that don't directly affect Lifecore Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Lifecore Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lifecore Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lifecore Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Lifecore Common Stock vs Short Term Investments Analysis

Common Stock vs Short Term Investments

Common Stock vs Short Term Investments Correlation Analysis

Correlation Coefficient

Common Stock

Short Term Investments

Lifecore Biomedical fundamental ratios Correlations

Lifecore Biomedical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Lifecore Biomedical fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Lifecore Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Cash
Non Current Assets Total	+ 0.98	Total Assets
Net Receivables	+ 0.97	Total Assets
Inventory	+ 0.95	Short Long Term Debt Total
Total Liab	+ 0.95	Short Long Term Debt Total

Common Stock	- 0.94	Common Stock Shares Outstanding
Cash And Short Term Investments	- 0.86	Property Plant And Equipment Net
Cash	- 0.86	Property Plant And Equipment Net
Cash And Short Term Investments	- 0.83	Net Debt
Cash	- 0.83	Net Debt
Inventory	- 0.81	Cash